TELMISTRUM CH 6.25

Description

TELMISTRUM CH 6.25 Telmisartan (40mg), Chlorthalidone (6.25mg) TELMISTRUM CH 6.25 offer a potent combination for managing hypertension (high blood pressure). This pairing utilizes two distinct mechanisms to lower blood pressure effectively, improving cardiovascular health and reducing the risk of related complications such as stroke and heart attack. Let's delve into each medication's role and their combined benefits in hypertension management. Telmisartan Class: Angiotensin II Receptor Blocker (ARB) Mechanism: Telmisartan works by blocking the action of angiotensin II, a hormone that causes blood vessels to narrow. By inhibiting the binding of angiotensin II to its receptors, Telmisartan helps relax and widen the blood vessels, thereby lowering blood pressure. Benefits: Beyond its blood pressure-lowering effects, Telmisartan is also associated with protective effects on the heart and kidneys, making it a preferred choice in patients with hypertension who have an increased risk of cardiovascular and renal diseases. Chlorthalidone Class: Thiazide-like Diuretic Mechanism: Chlorthalidone reduces blood pressure by promoting the elimination of sodium and water from the body, which decreases blood volume and, subsequently, the pressure exerted against artery walls. Although it's often classified with thiazide diuretics, Chlorthalidone has a longer duration of action and may be more effective in reducing cardiovascular outcomes. Benefits: Chlorthalidone not only lowers blood pressure but also has been shown to reduce the risk of heart failure and stroke in patients with hypertension. Its long-acting nature means it can provide a consistent blood pressure-lowering effect over 24 hours. Combined Therapy Rationale: TELMISTRUM CH 6.25 two different physiological pathways to lower blood pressure, which can be more effective than using either drug alone. This synergistic effect enhances blood pressure reduction and may offer additional cardiovascular protection. Advantages: For patients whose blood pressure is not adequately controlled with monotherapy, adding a second drug with a complementary mechanism of action can achieve better control. TELMISTRUM CH 6.25 may also allow for lower doses of each medication, potentially reducing the risk of side effects. For further information: Email: info@sterispharma.com / contact@sterispharma.com Call/WhatsApp: 7877551268, 7849827488 Buy Now: https://www.sterisonline.com/product/telmistrum-ch-6-25-133381